Integrum has been granted a registered trademark for OPRA® Implant System in the EU
Mölndal, Sweden – May 15, 2024 — Integrum (publ) (Nasdaq First North Growth Marketing: INTEG B) announces that the European Union Intellectual Property Office, EUIPO, has approved Integrum’s product registration application for the OPRA® Implant System.
Until now, the OPRA® Implant system has been an unregistered mark without legal protection.
As it is granted a registered trademark, Integrum now obtains unitary immaterial protection for the product in the entire territory of the EU.
“We are very pleased to have obtained a registered trademark for OPRA® as it grants us legal protection of the trademark in all EU countries, and we see it as another recognition of our unique offer,” says Rickard Brånemark, CEO of Integrum.
For more information, please contact:
Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: rickard.branemark@integrum.se
Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: Jorgen.svanstrom@integrum.se
Certified Adviser
Carnegie Investment Bank AB (publ) is Certified Adviser.